Download free PDF

North America Elderly Care Products Market Size & Share 2026-2035

Report ID: GMI16122
   |
Published Date: August 2026
 | 
Report Format: PDF/Excel/Dashboard/Platform

Download Free PDF

Explore Our Licensing Options:

North America Elderly Care Products Market Size

The North America elderly care products market was valued at USD 16.2 billion in 2025 and is projected to reach USD 26 billion by 2035, expanding at a 4.8% CAGR over 2026–2035. According to the latest report published by Global Market Insights Inc., demand is shifting from episodic purchases of single-purpose aids toward recurring, home-centered product portfolios that combine safety, monitoring, comfort, and self-management. The market is measured on a demand-side, revenue-only basis across the United States and Canada. It includes durable medical equipment, assistive devices, personal care consumables, nutritional supplements, hearing aids, respiratory equipment, mobility aids, bathroom safety products, comfort-care products, and daily living aids. It excludes pharmaceutical drugs, healthcare services, hospital capital infrastructure, general consumer products not designed for older users, and facility fees.

North America Elderly Care Products Market Key Takeaways

2025 Market Size
$ 16.2 Billion
2026 Market Size
$ 17 Billion
2035 Forecast Market Size
$ 26 Billion
CAGR (2026–2035)
4.8%
Regional Dominance
Largest Market
U.S.
Fastest Growing Country
U.S.
Key Players
  • Market Leader: Kimberly-Clark led with over 16% market share in 2025.

  • Leading Players: Top 5 players in this market include Kimberly-Clark, Essity, Medline Industries, Stryker Corporation, Abbott Nutrition, which collectively held a market share of 57% in 2025.

A validated estimate places revenue at USD 15,411 million in 2024, USD 16,151 million in 2025, and USD 25,811 million in 2035. The estimate combines company-revenue analysis (40% weighting), a bottom-up population and spending build (35%), and top-down validation against U.S. and Canadian health spending (25%). The three approaches were within a ±3.1% spread for 2024, and the weighted average was selected as the market estimate.

The underlying demand base is expanding, but its commercial effect is more specific than population growth alone. The U.S. population aged 65 and older reached 61.2 million in 2024 and is expected to approach 74 million by 2030. [1] Older households increasingly purchase products that defer a move into facility-based care, while care providers procure connected devices that extend monitoring beyond clinical settings. Medical devices, incontinence products, nutritional supplements, and mobility equipment therefore compete for the same household budget, even though their purchasing cycles differ.

North America carries a 10% average selling-price premium against the global average because of reimbursement, advanced product specifications, and direct-to-consumer pricing power. That premium supports revenue growth but also makes affordability central to product adoption. The market’s defining divide is not between clinical and consumer products; it is between products that reduce caregiver workload at home and those that require a caregiver or clinician to operate them.

GMI Analyst View

The market will remain a mature but durable growth category through 2035. Aging creates the demand floor, while home-based care changes the product mix toward devices and consumables that can be selected, installed, and used outside institutions. The more consequential shift will occur in channels: home-centered purchasing raises the value of simple setup, remote support, and replenishment models. By 2030, suppliers that connect safety, monitoring, and daily-living use cases will hold a stronger position than vendors selling isolated hardware alone.

Key Drivers

Driver Approx. CAGR Impact Impact Timeline
Expanding 65+ population +1.6% to +2.0% United States and Canada - sustained demand across all product categories Long term
Shift toward home-based care +0.9% to +1.2% United States-led - concentrated in home safety, monitoring, and mobility Medium term
Rising chronic disease burden +0.6% to +0.9% Regional - disproportionate demand for monitoring and respiratory products Long term
Healthcare spending and public programs +0.4% to +0.6% United States and Canada - institutional and home-care procurement Medium term
Smart assistive-device integration +0.3% to +0.5% Regional - led by connected medical devices and emergency alerts Long term

The U.S. aging population is the market’s most persistent growth driver. Census data places the 65+ population at 61.2 million in 2024, providing a large installed base for recurring incontinence, nutritional, and monitoring purchases. [1] As the 75+ cohort expands, demand shifts toward equipment that protects mobility and lowers fall risk. That shift supports both durable equipment and repeat consumables. It also increases the value of products that work without complex setup.

Home-based care changes where products are used and how they are purchased. ASPE/HHS reports that 95.7% of U.S. older adults live at home. [2] A home setting favors grab bars, anti-slip mats, adjustable beds, stair aids, remote patient monitoring systems, and telemedicine-compatible devices. CMS-reported home-health and home- and community-based services spending growth adds an institutional funding channel to household demand. [3] The second-order effect is a growing need for products that caregivers can understand without clinical training.

Chronic disease management expands the addressable use of blood pressure monitors, blood glucose monitors, pulse oximeters, respiratory aids, and nutritional products. Approximately 82% of U.S. older adults have at least one chronic condition in the validated market evidence. Products that turn intermittent clinical measurements into routine home data become more valuable when they reduce unnecessary visits or enable earlier intervention. The FDA’s 2022 OTC Hearing Aid Final Rule also widened consumer access to a category that had historically depended on more restrictive channels. [4]

Key Restraints

Restraint Approx. CAGR Impact Impact Timeline
High cost of advanced assistive devices -0.4% to -0.6% Regional - concentrated in hearing aids and advanced mobility devices Short term
Technology adoption barriers among older adults -0.2% to -0.4% Regional - greatest among the 75+ cohort and low-literacy users Short term
Medicare and Medicaid reimbursement gaps -0.1% to -0.3% United States - variable coverage across DME categories Medium term
Supply-chain and material pressures -0.1% to -0.2% Regional - medical-grade materials and battery-dependent devices Short term

Advanced assistive products can carry a high out-of-pocket burden, particularly where coverage does not match the product’s functional value. Price sensitivity limits adoption of premium hearing aids, sophisticated mobility equipment, and connected systems even when clinical need is clear. Suppliers are responding with lower-cost lines, simplified designs, and direct-to-consumer offers. The commercial implication is that premium product growth depends on demonstrating caregiver time savings or safer independent living, not only technical features.

Digital tools also face a usability constraint. Older users may avoid products that require repeated app navigation, charging, account management, or unclear alerts. This does not remove demand for connected care; it shifts design priorities toward visible interfaces, fewer setup steps, and caregiver-accessible controls. Reimbursement variation adds uncertainty because product eligibility can differ across DME categories and supplemental plans. These constraints favor suppliers with channel support, training, and service capacity.

GMI Analyst View

Demand drivers outweigh restraints, but the forecast does not assume that every smart device reaches mass adoption. The strongest products will be those that fit into daily routines without forcing older adults to learn a new care workflow. Reimbursement and affordability will continue to determine how quickly advanced devices move beyond affluent households. By 2028, ease of use and care-team interoperability will matter as much as sensor capability.

North America Elderly Care Products Market Segment Analysis

By Product Type

Medical devices represented the largest product category, generating USD 3.3 billion in 2025 in the ORCA narrative; the validated 2024 estimate was USD 3,390 million, or 22% of regional revenue. The category includes hearing aids and assistive listening devices, blood pressure and cardiac monitors, blood glucose monitors, pulse oximeters, respiratory aids, and remote patient monitoring systems. FDA action on OTC hearing aids supports consumer-direct access, while remote monitoring brings more clinical data into the home. [4] Medical devices are projected to grow at 5.4% through 2035, alongside mobility products at 5.4%.

North America Elderly Care Products Market Size, By Product Type, 2022 – 2035 (USD Billion)

Nutritional supplements represented 20% of 2024 revenue, followed by incontinence products at 16%, mobility products at 14%, comfort care at 12%, bathroom safety at 8%, and daily living aids and others at 8%. Product breadth matters because older consumers often need several categories simultaneously. Wheelchairs, rollators, mobility scooters, canes, crutches, stair lifts, and hoists address movement. Grab bars, handrails, shower chairs, bath seats, commode chairs, and toilet-seat raisers reduce risk in the bathroom. Adjustable beds, pressure-relief mattresses, therapeutic wraps, bed rails, and riser recliners serve comfort and recovery needs.

Incontinence pads, liners, absorbent underwear, adult diapers, underpads, bed protectors, external catheters, and urinary sheaths create a recurring-revenue base. Multi-vitamin and mineral combinations, protein and meal replacements, fiber products, food thickeners, and dysphagia-management products extend care into nutrition. Adaptive kitchen utensils, dressing and grooming aids, magnifiers, pill organizers, vision aids, communication aids, and emergency alerts complete the daily-living category. By 2035, the product mix will favor categories that join monitoring or prevention with a practical household task.

By Care Type

Home care and independent living support is the central care-type use case because most older adults remain in private residences. It pulls demand across mobility, safety, personal care, and connected monitoring rather than creating a single-product category. Chronic disease management centers on routine measurement and respiratory support, including blood glucose monitors, blood pressure monitors, pulse oximeters, CPAP/APAP devices, and remote patient monitoring systems. These products benefit when users and caregivers can share readings without an in-person visit.

Post-acute rehabilitation care relies on mobility aids, beds, pressure-relief products, bathroom safety equipment, and rehabilitation-oriented devices after discharge. Palliative and end-of-life care prioritizes comfort products, pressure management, hygiene, nutrition, and caregiver usability. Preventive health management links hearing assistance, monitoring devices, nutritional supplements, fall-prevention equipment, and daily living aids. The care-type structure shows that a single product can serve more than one setting; channel and payer decisions will increasingly determine the final purchase path.

By End Use

Home-based care led the end-use structure, accounting for 39.6% in 2025 in the ORCA narrative and USD 6,935 million, or 45%, in the validated 2024 estimate. Its forecast share rises to 52% by 2035, supported by a 6.1% CAGR. Home users favor grab bars, anti-slip mats, adjustable beds, stair aids, emergency alerts, and monitoring devices that make a residence safer without requiring a facility move. The demand shift is reinforced by the 95.7% at-home living rate among U.S. older adults. [2]

North America Elderly Care Products Market Revenue Share (%), By End Use, (2025)

Hospitals and clinics represented 20% of 2024 revenue, nursing homes and skilled nursing facilities 14%, assisted living and continuing care retirement communities 15%, and adult day care and rehabilitation centers 6%. Institutional procurement retains importance for clinically specific equipment, but its share declines where equipment is prescribed or purchased for home use. Nursing homes and SNFs are projected to grow more slowly than home-based care, while assisted living and CCRCs will gain relevance as the baby-boom cohort enters later-life housing. The end-use mix favors suppliers able to serve both professional buyers and family purchasers.

By Distribution Channel

Offline channels led in 2025 with USD 12.1 billion in revenue in the ORCA narrative. The validated 2024 estimate places offline revenue at USD 10,479 million, or 68%, compared with USD 4,932 million, or 32%, online. Pharmacies and medical supply stores, specialty DME retailers, and hospital and institutional procurement provide physical assessment, product fitting, and staff guidance. Those features remain valuable for hospital beds, mobility aids, bathroom safety products, and personal care equipment where comfort and usability cannot be judged fully from an online listing.

Online sales will grow at an 8.2% CAGR through 2035 and are expected to reach 46% share. E-commerce websites and brand websites make replenishment easier for incontinence products, supplements, and selected daily living aids. Direct ordering also supports discreet purchases and subscription models. The channel will not simply replace physical retail; it will separate replenishable, standardized items from higher-consideration products that benefit from fitting and professional advice.

GMI Analyst View

Segment growth will increasingly follow the care setting rather than traditional product labels. Medical devices and mobility products gain when they help users stay at home, while consumables gain when they simplify repeat purchasing. Online growth will be strongest in categories with predictable replenishment, whereas specialized DME will continue to depend on offline fitting and institutional procurement. By 2030, suppliers with an integrated product and service proposition will be better placed than suppliers organized around a single category.

North America Elderly Care Products Market Regional Analysis

U.S.

The United States remains the principal revenue center. The validated allocation placed U.S. revenue at USD 13,562 million in 2024, or 88% of North American revenue, and projects USD 22,714 million by 2035. The ORCA 2025 market-page narrative separately recorded a 72.8% U.S. share and approximately USD 11.8 billion in revenue; that legacy figure is retained as an unreconciled reference because its country allocation differs from the validated base-year model. The larger validated allocation reflects a demand-side split for the United States and Canada.

U.S. Elderly Care Products Market Size, 2022 - 2035 (USD Billion)

The U.S. market is supported by a large 65+ population, high healthcare spending, Medicare and Medicaid reimbursement channels, and developed retail and medical-supply networks. OTC hearing aid availability is one regulatory access point for consumer medical devices. [4] The major constraint is uneven reimbursement for advanced DME and connected products. As home use expands, suppliers must translate clinical features into intuitive consumer benefits and provide support beyond the point of sale.

Canada

Canada represented USD 1,849 million, or 12%, of validated North American revenue in 2024 and is projected to reach USD 3,097 million by 2035. Its demand base is supported by population aging, universal healthcare, provincial long-term-care programs, and home-care subsidies in Ontario, British Columbia, and Alberta. Statistics Canada provides the demographic foundation for this aging trend. [5]

Canada shares the region’s demand for home safety, mobility, personal care, and monitoring products, but provincial funding and procurement systems shape access differently from the United States. The practical constraint is fragmentation across provincial programs and purchasing pathways. That makes distributor coverage, reimbursement knowledge, and product adaptability more important than a uniform North American commercial model.

GMI Analyst View

The United States will continue to set the region’s revenue trajectory, while Canada offers a smaller but structurally attractive market for home-care and long-term-care products. The two countries share demographic pressure but not the same funding mechanisms. Through 2035, suppliers that adapt pricing, channel support, and reimbursement navigation by country will outperform firms relying on a single regional offer.

North America Elderly Care Products Market Share & Competitive Landscape

Kimberly-Clark led the ORCA competitive narrative with a 16% market share. Kimberly-Clark, Essity, Medline Industries, Stryker Corporation, and Abbott Nutrition collectively accounted for approximately 57%, characterizing the market as moderately fragmented. The validated Pre-ME company-revenue model separately ranked Medline Industries first at 17% in 2024. The difference reflects separate competitive evidence sets; the RD retains the ORCA market-share leadership statement for the narrative and does not substitute an unsupported reconciliation.

Major players operating in the North America elderly care products market include:

Global players: Invacare Corporation supplies wheelchairs, mobility scooters, respiratory products, and home-care beds. Medline Industries serves incontinence, daily living, and institutional supply needs. Stryker Corporation addresses healthcare workflows and connected clinical environments. Arjo participates in patient handling and care equipment. Essity concentrates on incontinence care and personal hygiene. Kimberly-Clark participates through Depend and related personal-care offerings. Abbott Nutrition serves nutritional supplements through products such as Ensure and Glucerna. Abbott’s FY2024 filing supports its nutrition segment relevance. [6]

Regional players: Drive Medical supplies mobility, bathroom safety, and related equipment. Graham-Field Health Products provides mobility aids, patient lifts, beds, and bathroom safety products. Carex Health Brands offers everyday mobility and home-safety aids. Dynarex Corporation sells disposable medical products, personal care items, wound care products, and durable medical equipment. Enovis Corporation participates in rehabilitation and mobility-adjacent products. First Quality Enterprises contributes personal-care and absorbent-product capabilities. EZ-ACCESS supplies accessibility products focused on ramps and mobility access.

Emerging players: Medical Guardian and Bay Alarm Medical focus on personal emergency response and monitoring. Stander Inc. addresses bed rails, mobility, and daily living aids. Silverts Adaptive Clothing & Footwear serves adaptive apparel needs. Kinova Inc. develops assistive robotics and related technology. Broda Seating provides specialized seating. Vayyar Imaging supplies 4D radar-based fall detection. These companies illustrate the market’s shift toward autonomy, safety, and caregiver visibility rather than a single clinical-device category.

Competitive differentiation is concentrated in distribution reach, recurring consumables, connected-care capability, and product usability. Kimberly-Clark and Essity gain from personal-care scale and repeat demand. Medline benefits from institutional relationships. Invacare, Graham-Field, Drive Medical, and EZ-ACCESS compete around durable equipment, access, and home adaptation. Stryker’s March 2026 SmartHospital launch and Sync Badge rollout show how provider-workflow technologies can influence care settings even when the final user is an older adult.

GMI Analyst View

The market is unlikely to consolidate around one product architecture because consumables, DME, nutrition, and monitoring systems have different economics and buying channels. Scale remains valuable in recurring categories, while specialized firms can defend positions through fitting, service, or distinctive safety technology. The second-order effect is that partnerships between product vendors and care providers will become more important as households seek coordinated solutions. By 2030, competitive advantage will depend on reducing the burden on both the older user and the caregiver.

Recent Industry Developments

  • Mar 2026: Stryker Corporation launched the SmartHospital platform, connecting medical devices, patient data, and workflows to improve care coordination and operational efficiency in healthcare environments. The launch links older-adult care demand with provider workflow integration.
  • Nov 2025: Invacare Corporation launched the Aquatec Pure Cala raised toilet seat with tool-free installation, anti-slip stability, and ergonomic locking mechanisms. The product addresses bathroom safety and independent use at home.
  • Mar 2025: Vayyar Imaging expanded deployment of its 4D radar-based fall-detection system for continuous, non-contact monitoring without cameras or wearables. The development supports privacy-conscious home safety monitoring.
  • Mar 2025: Stryker Corporation introduced the Sync Badge wearable communication device for hands-free, voice-controlled communication. The device can improve caregiver responsiveness in care environments.
  • 2024: Essity introduced updated incontinence briefs with improved core absorption technology and body-fit design. The product update reinforces the importance of comfort and leakage protection in recurring personal-care purchases.

North America Elderly Care Products Market Research Report

Need a specific section of this report?

Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.

Authors:  Avinash Singh, Amit Patil

Table of Contents

Chapter 1   Methodology and Scope

Chapter 2   Executive Summary

Chapter 3   Industry Insights

Chapter 4   Competitive Landscape, 2025

Chapter 5   Market Estimates and Forecast, By Product Type, 2022 – 2035 (USD Billion) (Thousand Units)

Chapter 6   Market Estimates and Forecast, By Care Type, 2022 – 2035 (USD Billion) (Thousand Units)

Chapter 7   Market Estimates and Forecast, By End Use, 2022 – 2035 (USD Billion) (Thousand Units)

Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2022 – 2035 (USD Billion) (Thousand Units)

Chapter 9   Market Estimates and Forecast, By Country, 2022 – 2035 (USD Billion) (Thousand Units)

Chapter 10   Company Profiles

Frequently Asked Question(FAQ) :
How big is the north america elderly care products market?
The north america elderly care products market size was estimated at USD 16.2 billion in 2025 and is expected to reach USD 17 billion in 2026.
What is the 2035 forecast for the north america elderly care products market?
The market is projected to reach USD 26 billion by 2035, growing at a CAGR of 4.8% from 2026 to 2035.
Which country dominates the north america elderly care products market?
U.S. currently holds the largest share of the north america elderly care products market in 2025.
Which country is expected to grow the fastest in the north america elderly care products market?
U.S. is projected to be the fastest-growing country during the forecast period.
Who are the major players in north america elderly care products market?
Some of the major players in north america elderly care products market include Kimberly-Clark, Essity, Medline Industries, Stryker Corporation, Abbott Nutrition, which collectively held 57% market share in 2025.
How much revenue did the medical devices segment generate in 2025?
Medical devices generated USD 3.3 billion in 2025, due to high demand for chronic disease monitoring and health management equipment.
What was the market share of the home-based care segment in 2025?
The home-based care segment held the largest end-use share at 39.6% in 2025, as elderly consumers increasingly prefer to receive care at home for independence, comfort, and cost reasons.

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Authors:  Avinash Singh, Amit Patil
We use cookies to enhance user experience. (Privacy Policy)